Poster & Publications

Circulating Nucleosome Immunoassay: Evaluating a Clinically-Applicable Test to Risk Stratify COVID-19

June 21, 2021

Share
Tweet
Share on Facebook
Share

Paper titled: “Circulating Nucleosome Immunoassay: Evaluating a Clinically-Applicable Test to Risk Stratify COVID-19 and Target Anticoagulation”

Presented at ISTH 2022

Rea et al

Download

Related Articles

Poster & Publications
Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients
Poster & Publications
Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA